Eden Super Speciality Hospital Profile
Key Indicators
- Authorised Capital ₹ 8.00 M
as on 06-07-2024
- Paid Up Capital ₹ 6.00 M
as on 06-07-2024
- Company Age 10 Year, 11 Months
- Last Filing with ROC 31 Mar 2015
- Revenue 96.29%
(FY 2015)
- Profit -241.88%
(FY 2015)
- Ebitda 574.77%
(FY 2015)
- Net Worth -1.69%
(FY 2015)
- Total Assets 0.69%
(FY 2015)
About Eden Super Speciality Hospital
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2015. It's a company limited by shares with an authorized capital of Rs 8.00 M and a paid-up capital of Rs 6.00 M, as per Ministry of Corporate Affairs (MCA) records.
Gauri Prasad, Sunil Kumar, Sujeet Kumar, and Ten other members serve as directors at the Company.
- CIN/LLPIN
U85100BR2014PTC021779
- Company No.
021779
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
06 Jan 2014
- Date of AGM
30 Sep 2015
- Date of Balance Sheet
31 Mar 2015
- Listing Status
Unlisted
- ROC Code
Roc Patna
Industry
Company Details
- Location
Patna, Bihar, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Eden Super Speciality Hospital?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pushpendra Kumar  | Managing Director | 06-Jan-2014 | Current |
Board Members(12)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Gauri Prasad | Director | 06-Jan-2014 | Current |
| Sunil Kumar | Director | 06-Jan-2014 | Current |
| Sujeet Kumar | Director | 06-Jan-2014 | Current |
| Rishi Kapoor | Director | 06-Jan-2014 | Current |
| Rashmi Ranjan | Director | 06-Jan-2014 | Current |
| Rajeev Nayan | Director | 06-Jan-2014 | Current |
Financial Performance of Eden Super Speciality Hospital.
Eden Super Speciality Hospital Private Limited, for the financial year ended 2015, experienced significant growth in revenue, with a 96.29% increase. The company also saw a substantial fall in profitability, with a 241.88% decrease in profit. The company's net worth dipped by a decrease of 1.69%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Eden Super Speciality Hospital?
In 2015, Eden Super Speciality Hospital had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Eden Super Speciality Hospital?
Unlock and access historical data on people associated with Eden Super Speciality Hospital, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Eden Super Speciality Hospital, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Eden Super Speciality Hospital's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
